(Q47754436)

5 February 2018

title

AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2. (English)

1 reference

5 February 2018

1 reference

1 reference

B Jiao

1

1 reference

5 February 2018

C-F Wu

2

1 reference

5 February 2018

Y Liang

3

1 reference

5 February 2018

H-M Chen

4

1 reference

5 February 2018

S-M Xiong

5

1 reference

5 February 2018

B Chen

6

1 reference

5 February 2018

J-Y Shi

7

1 reference

5 February 2018

Y-Y Wang

8

1 reference

5 February 2018

J-H Wang

9

1 reference

5 February 2018

Y Chen

10

1 reference

5 February 2018

J-M Li

11

1 reference

5 February 2018

L-J Gu

12

1 reference

5 February 2018

J-Y Tang

13

1 reference

5 February 2018

Z-X Shen

14

1 reference

5 February 2018

B-W Gu

15

1 reference

5 February 2018

W-L Zhao

16

1 reference

5 February 2018

Z Chen

17

1 reference

5 February 2018

S-J Chen

18

1 reference

5 February 2018

publication date

21 May 2009

1 reference

5 February 2018

published in

Leukemia

1 reference

5 February 2018

volume

23

1 reference

5 February 2018

issue

9

1 reference

5 February 2018

page(s)

1598-1604

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1038/leu.2009.104

exact match

0 references

cites work

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Acute myeloid leukemia M2B (subacute myeloid leukemia) in China

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Class III receptor tyrosine kinases: role in leukaemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Clinical characteristics and outcomes in patients with t(8;21) acute myeloid leukemia in Japan

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Immunophenotypic profile predictive of KIT activating mutations in AML1-ETO leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.104

7 January 2021

Identifiers

DOI

10.1038/LEU.2009.104

1 reference

5 February 2018

1 reference

5 February 2018